ZA9201025B - Structural gene of pneumococcal protein - Google Patents

Structural gene of pneumococcal protein

Info

Publication number
ZA9201025B
ZA9201025B ZA921025A ZA9201025A ZA9201025B ZA 9201025 B ZA9201025 B ZA 9201025B ZA 921025 A ZA921025 A ZA 921025A ZA 9201025 A ZA9201025 A ZA 9201025A ZA 9201025 B ZA9201025 B ZA 9201025B
Authority
ZA
South Africa
Prior art keywords
structural gene
pneumococcal protein
pneumococcal
protein
gene
Prior art date
Application number
ZA921025A
Inventor
David E Briles
Janet L Yother
Larry S Mcdaniel
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US65677391A priority Critical
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of ZA9201025B publication Critical patent/ZA9201025B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
ZA921025A 1991-02-15 1992-02-12 Structural gene of pneumococcal protein ZA9201025B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US65677391A true 1991-02-15 1991-02-15

Publications (1)

Publication Number Publication Date
ZA9201025B true ZA9201025B (en) 1992-11-25

Family

ID=24634503

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921025A ZA9201025B (en) 1991-02-15 1992-02-12 Structural gene of pneumococcal protein

Country Status (16)

Country Link
US (1) US5728387A (en)
EP (2) EP0571538B1 (en)
JP (3) JP3215109B2 (en)
AT (1) AT168132T (en)
AU (1) AU692678C (en)
CA (1) CA2104014C (en)
DE (2) DE69226167D1 (en)
DK (1) DK0571538T5 (en)
ES (1) ES2118812T3 (en)
FI (1) FI933580A (en)
HK (1) HK1013629A1 (en)
IE (2) IE920479A1 (en)
IL (1) IL100946D0 (en)
NO (1) NO313999B1 (en)
WO (1) WO1992014488A1 (en)
ZA (1) ZA9201025B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004802A (en) * 1995-06-02 1999-12-21 University Of Alabama At Birmingham Oral administration of pneumococcal antigens
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US6232116B1 (en) 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
US5965141A (en) * 1991-02-15 1999-10-12 Uab Research Foundation Epitopic regions of pneumococcal surface protein a
AU709368B2 (en) * 1995-06-02 1999-08-26 Uab Research Foundation Oral administration of pneumococcal antigens
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
AU734488B2 (en) * 1994-05-20 2001-06-14 Uab Research Foundation Mucosal administration of pneumococcal antigens
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6231870B1 (en) * 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
AT339436T (en) * 1995-06-07 2006-10-15 Sanofi Pasteur Inc Expression of lipoproteins
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
JPH11507214A (en) * 1995-06-07 1999-06-29 バイオケム ヴァシーンズ インク. Heat shock protein members of streptococci belonging to the Hsp70 family
ZA9604896B (en) 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US20010016200A1 (en) * 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US5949537A (en) 1996-04-18 1999-09-07 American Air Liquide Inc. In-line cell for absorption spectroscopy
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
AU737243B2 (en) 1996-07-03 2001-08-16 Merial, Inc. Recombinant canine adenovirus (CAV) containing exogenous DNA
US5882896A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
CA2274095A1 (en) * 1996-12-04 1998-06-11 University Of Alabama At Birmingham Compositions and methods for administering pneumococcal dna
KR19980067137A (en) * 1997-01-31 1998-10-15 박원훈 Pneumonia using alginate ultrafine granulocyte aureus vaccines for the sense of the year
AU9574598A (en) * 1997-09-18 1999-04-05 Pasteur Merieux Connaught Improved method of production of pneumococcal surface proteins
US6224882B1 (en) 1997-11-07 2001-05-01 Protein Science Corp. Insect cells or fractions as adjuvant for antigens
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
WO2001023604A2 (en) 1999-09-28 2001-04-05 Infectio Diagnostic (I.D.I.) Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AT410412B (en) 2000-11-10 2003-04-25 Inteco Int Techn Beratung A method of electro-slag remelting metals
EP2275125A3 (en) * 2002-04-02 2011-03-09 Ben Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US8691243B2 (en) 2002-04-02 2014-04-08 Ben-Gurion University Of The Negev Research And Development Authority Protein-based Streptococcus pneumoniae vaccine
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
PT1968631E (en) 2005-12-22 2015-07-20 Glaxosmithkline Biolog Sa Vaccine
UA92782C2 (en) 2006-01-17 2010-12-10 Арне Форсгрен Novel surface exposed haemophilus influenzae protein (protein e - pe)
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
KR20100045445A (en) 2007-06-26 2010-05-03 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CN102099052A (en) 2008-04-16 2011-06-15 葛兰素史密丝克莱恩生物有限公司 vaccine
ES2570973T3 (en) 2008-05-02 2016-05-23 Products and methods for stimulating an immune response
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
US20130011424A1 (en) 2010-03-09 2013-01-10 Timur ARTEMEV Polyepitope constructs and methods for their preparation and use
KR20190027955A (en) 2010-05-14 2019-03-15 박스알타 인코퍼레이티드 Ospa chimeras and use thereof in vaccines
US9109007B2 (en) 2010-08-18 2015-08-18 Purdue Pharma L.P. MHC-I restricted epitopes containing non-natural amino acid residues
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2014018274A1 (en) 2012-07-27 2014-01-30 Baxter International, Inc. Compositions comprising chimeric ospa molecules and methods of use thereof
CN104812405A (en) 2012-09-19 2015-07-29 国立大学法人大阪大学 Pneumococcal vaccine containing pneumococcal surface protein a
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine

Also Published As

Publication number Publication date
DK0571538T3 (en) 1999-04-19
EP0571538A1 (en) 1993-12-01
DE69226167T2 (en) 1998-11-12
HK1013629A1 (en) 2000-05-26
JPH09224680A (en) 1997-09-02
AU692678B2 (en) 1998-06-11
JP3215109B2 (en) 2001-10-02
CA2104014C (en) 2000-05-02
FI933580D0 (en)
AU692678C (en) 2002-08-29
DE69226167D1 (en) 1998-08-13
DK571538T3 (en)
FI933580A (en) 1993-10-13
IL100946D0 (en) 1992-11-15
NO313999B1 (en) 2003-01-13
JP2001204482A (en) 2001-07-31
AU1445392A (en) 1992-09-15
AT168132T (en) 1998-07-15
AU667668B2 (en) 1996-04-04
ES2118812T3 (en) 1998-10-01
AU4798096A (en) 1996-06-27
DK571538T5 (en)
FI933580A0 (en) 1993-08-13
WO1992014488A1 (en) 1992-09-03
NO932890D0 (en) 1993-08-13
IE920479A1 (en) 1992-08-26
IE20000062A1 (en) 2000-12-13
JPH06504446A (en) 1994-05-26
CA2104014A1 (en) 1992-08-16
NO932890L (en) 1993-10-14
DK0571538T5 (en) 2002-03-04
EP0786521A1 (en) 1997-07-30
EP0571538B1 (en) 1998-07-08
EP0571538A4 (en) 1994-08-24
US5728387A (en) 1998-03-17

Similar Documents

Publication Publication Date Title
AU610636B2 (en) Stabilised human protein preparations
AU608706B2 (en) Purification of hepetitis proteins
AU637688B2 (en) Hair drier
IE63765B1 (en) Method for the purification of proteins
NZ241367A (en) Pneumococcal polysaccharide-immunogenic protein conjugate
CZ197595A3 (en) Vaccine preparations
ZA9200467B (en) Mixed specificity fusion proteins
SG46476A1 (en) Protein production and protein delivery
GB8819209D0 (en) Polypeptide & dna encoding same
IE914504A1 (en) Optimization of binding proteins
PT924299E (en) Sequence of transit peptid dna
GB8707412D0 (en) Peptide compounds
PT672138E (en) Cogulating quimeric proteins
GB8927722D0 (en) Proteins and nucleic acids
HU9301510D0 (en) Inhibition of interaction of protein causing cell adhession and carbonhydrate
GB9014932D0 (en) Recombinant dna product and method
PL169562B1 (en) Method of obtaining novel peptides
AU1884392A (en) Peptide nucleic acids
HU9400110D0 (en) Production of antibodies
SG44652A1 (en) Protein delivery and protein production
IE63424B1 (en) Yeast vector
ZA9309621B (en) Protein named component B
ZA8805192B (en) Pharmaceutical preparations
IE911276A1 (en) Granulated preparations and method of producing the same
GB8717430D0 (en) Recombinant dna product